FDA approves Teva’s generic nasal spray to treat opioid overdose

Published 5y ago

(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said. This is the first approval of a gene... More »